US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Akt2 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Akt2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Akt2 Inhibitors- ...  |  read more...
USD 1,250
Akt3 Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Akt3 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Akt3 Inhibitors- ...  |  read more...
USD 1,250
Aldose Reductase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aldose Reductase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Aldosterone Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aldosterone Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Aldosterone Antagonists- ...  |  read more...
USD 1,250
Alpha 4 Beta 7 (A4b7) Integrin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Beta 7 (A4b7) Integrin Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha 4 Beta 7 (A4b7) Integrin Inhibitors Report helps ...  |  read more...
USD 1,250
Alpha Receptor Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Alpha Receptor Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha Receptor Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Alpha Tubulin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha Tubulin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Alpha v Beta 6 Integrin Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Integrin Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha v Beta 6 Integrin Antagonists Report helps to identify emerging players ...  |  read more...
USD 1,250
Alpha-1A Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-1A Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-1A Agonists- ...  |  read more...
USD 1,250
Alpha-1A Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-1A Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-1A Antagonists- ...  |  read more...
USD 1,250
Alpha-2 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-2 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-2 Agonists- ...  |  read more...
USD 1,250
Alpha-2A Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-2A Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-2A Agonists- ...  |  read more...
USD 1,250
Alpha-2B Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-2B Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-2B Agonists- ...  |  read more...
USD 1,250
Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2) -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Alpha2beta1 Integrin Antagonists (Very Late Antigen 2 (VLA-2). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha2beta1 Integrin Antagonists (Very Late Antigen ...  |  read more...
USD 1,250
Alpha-2C Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-2C Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Alpha-2C Antagonists- ...  |  read more...
USD 1,250
Alpha-Synuclein (alphaSyn or SNCA) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Alpha-Synuclein (alphaSyn or SNCA) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
AMPK Beta Activators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The AMPK Beta Activators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Androgen Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Androgen Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Androgen Antagonists- ...  |  read more...
USD 1,250
Angiopoietin 2 (Ang-2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiopoietin 2 (Ang-2) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Angiopoietin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiopoietin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Angiopoietin Inhibitors- ...  |  read more...
USD 1,250
Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiotensin Converting Enzyme (ACE) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Angiotensin II Receptor Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiotensin II Receptor Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiotensin II Receptor Type 1 (AT1 ...  |  read more...
USD 1,250
Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiotensin II Receptor Type 2 (AT2 ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15